- m-PEG8-Tos
-
-
2025-06-07
- CAS:79622-11-0
- Min. Order: 1g
- Purity: >98.00%
- Supply Ability: 1g
|
| | m-PEG7-OTs Basic information |
| Product Name: | m-PEG7-OTs | | Synonyms: | MPEG8-TOSYLATE;m-PEG8-OTs;Alpha-methoxy-omega-(4-methylbenzenesulfonate) hepta(ethylene glycol);2,5,8,11,14,17,20-heptaoxadocosan-22-yl 4-methylbenzene-1-sulfonate;TosO-(CH2CH2O)7-Me;Methyl octapolyethylene glycol p-toluene sulfonate;2,5,8,11,14,17,20-heptaoxadocosan-22-yl 4-methylbenzenesulfonate;3,6,9,12,15,18,21-Heptaoxadocosan-1-ol, 1-(4-methylbenzenesulfonate) | | CAS: | 79622-11-0 | | MF: | C22H38O10S | | MW: | 494.6 | | EINECS: | | | Product Categories: | | | Mol File: | 79622-11-0.mol |  |
| | m-PEG7-OTs Chemical Properties |
| Boiling point | 567.6±50.0 °C(Predicted) | | density | 1.151±0.06 g/cm3(Predicted) |
| | m-PEG7-OTs Usage And Synthesis |
| Description | m-PEG8-Tos is a PEG linker containing a tosyl group. The tosyl group is a very good leaving group for nucleophilic substitution reactions. The hydrophilic PEG spacer increases solubility in aqueous media. | | Uses | m-PEG7-Tos is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. | | IC 50 | PEGs | | References | [1] An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 DOI:10.1016/j.ebiom.2018.09.005 |
| | m-PEG7-OTs Preparation Products And Raw materials |
|